{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:47:19Z","timestamp":1786981639446,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:00:00Z","timestamp":1717286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:00:00Z","timestamp":1717286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010607","name":"Universit\u00e0 degli Studi di Perugia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010607","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nearly one fifth of patients with venous thromboembolism (VTE) have cancer. When both of these conditions occur, especially in cases of cerebral vein thrombosis (CVT), patient management is often challenging. The aim of this study was to compare the characteristics and event courses in patients affected by CVT with and without cancer. Consecutive patients with CVT from the ACTION-CVT cohort study were included if cancer status was reported. Risk factors as well as the clinical and radiological characteristics of patients were compared. Univariable and multivariable analyses were performed to assess variables associated with cancer. Kaplan-Meier method and log-rank test, logistic regression analysis, and propensity score matching were used to investigate any association between cancer-related CVT and study outcomes (primary outcome at 3-months: recurrent VTE or major hemorrhage; recurrent VTE; major hemorrhage; recanalization status; all-cause-death). Overall, 1,023 patients with CVT were included, of which 6.5% had cancer. Older age (adjusted odds ratio [aOR] 1.28 per decade increase; 95% confidence interval [CI] 1.08\u20131.52) and absence of headache (aOR 0.47; 95% CI 0.27\u20130.84) were independently associated with cancer. Patients with cancer had a higher risk of recurrent VTE or major hemorrhage (aOR 3.87; 95% CI 2.09\u20137.16), all-cause-death (aOR 7.56 95% CI 3.24\u201317.64), and major hemorrhage (aOR 3.70 95% CI 1.76\u20137.80). Recanalization rates, partial or complete, was not significantly different. CVT patients with cancer were more likely to be older, have no referred headache, and have worse outcomes compared to CVT patients without cancer.<\/jats:p>","DOI":"10.1007\/s11239-024-02997-w","type":"journal-article","created":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T10:01:24Z","timestamp":1717322484000},"page":"1008-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2268-9983","authenticated-orcid":false,"given":"Maria Cristina","family":"Vedovati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqi","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Henninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel S.","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam R.","family":"Heldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Al Kasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Siegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Liebeskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Antonenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Yaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,2]]},"reference":[{"issue":"1","key":"2997_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1055\/s-0038-1657512","volume":"78","author":"G Agnelli","year":"1997","unstructured":"Agnelli G (1997) Venous thromboembolism and cancer: a two-way clinical association. Thromb Haemost 78(1):117\u2013120 PMID: 9198139","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"2997_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/sj.bjc.6605599","volume":"102","author":"S Noble","year":"2010","unstructured":"Noble S, Pasi J (2010) Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer 102(Suppl 1):S2\u20139","journal-title":"Br J Cancer"},{"issue":"6","key":"2997_CR3","doi-asserted-by":"publisher","first-page":"e0128741","DOI":"10.1371\/journal.pone.0128741","volume":"10","author":"I Mah\u00e9","year":"2015","unstructured":"Mah\u00e9 I, Sterpu R, Bertoletti L, L\u00f3pez-Jim\u00e9nez L, Mellado Joan M, Trujillo-Santos J, Ballaz A, Hern\u00e1ndez Blasco LM, Marchena PJ, Monreal M (2015) RIETE investigators. Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? PLoS ONE 10(6):e0128741","journal-title":"PLoS ONE"},{"issue":"3","key":"2997_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","volume":"35","author":"JM Ferro","year":"2004","unstructured":"Ferro JM, Canh\u00e3o P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 35(3):664\u2013670","journal-title":"Stroke"},{"issue":"1","key":"2997_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2008.01059.x","volume":"119","author":"W Grisold","year":"2009","unstructured":"Grisold W, Oberndorfer S, Struhal W (2009) Stroke and cancer: a review. Acta Neurol Scand 119(1):1\u201316","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"2997_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1160\/TH09-12-0873","volume":"103","author":"I Martinelli","year":"2010","unstructured":"Martinelli I, De Stefano V (2010) Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review. Thromb Haemost 103(6):1136\u20131144","journal-title":"Thromb Haemost"},{"issue":"12 Pt 2","key":"2997_CR7","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.1016\/j.lpm.2016.10.007","volume":"45","author":"JM Ferro","year":"2016","unstructured":"Ferro JM, Canh\u00e3o P, Aguiar de Sousa D (2016) Cerebral venous thrombosis. Presse Med 45(12 Pt 2):e429\u2013e450","journal-title":"Presse Med"},{"issue":"4","key":"2997_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1182\/blood-2005-12-4795","volume":"108","author":"F Dentali","year":"2006","unstructured":"Dentali F, Gianni M, Crowther MA, Ageno W (2006) Natural history of cerebral vein thrombosis: a systematic review. Blood 108(4):1129\u20131134","journal-title":"Blood"},{"issue":"4","key":"2997_CR9","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY, American Heart Association Stroke Council and the Council on Epidemiology and Prevention (2011) Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42(4):1158\u20131192","journal-title":"Stroke"},{"issue":"19","key":"2997_CR10","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, Thurston C, Vedantham S, Verhamme P, Witt DM, Florez D, Izcovich I, Nieuwlaat A, Ross R, Sch\u00fcnemann SJ, Wiercioch H, Zhang W, Zhang Y (2020) American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4(19):4693\u20134738","journal-title":"Blood Adv"},{"issue":"10","key":"2997_CR11","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100(10):3484\u20133488","journal-title":"Blood"},{"issue":"25","key":"2997_CR12","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1182\/blood-2014-01-549733","volume":"123","author":"CE Chee","year":"2014","unstructured":"Chee CE, Ashrani AA, Marks RS, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA (2014) Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood 123(25):3972\u20133978","journal-title":"Blood"},{"issue":"3","key":"2997_CR13","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/STROKEAHA.121.037541","volume":"53","author":"S Yaghi","year":"2022","unstructured":"Yaghi S, Shu L, Bakradze E, Salehi Omran S, Giles JA, Amar JY, Henninger N, Elnazeir M, Liberman AL, Moncrieffe K, Lu J, Sharma R, Cheng Y, Zubair AS, Simpkins AN, Li GT, Kung JC, Perez D, Heldner M, Scutelnic A, Seiffge D, Siepen B, Rothstein A, Khazaal O, Do D, Kasab SA, Rahman LA, Mistry EA, Kerrigan D, Lafever H, Nguyen TN, Klein P, Aparicio H, Frontera J, Kuohn L, Agarwal S, Stretz C, Kala N, El Jamal S, Chang A, Cutting S, Xiao H, de Havenon A, Muddasani V, Wu T, Wilson D, Nouh A, Asad SD, Qureshi A, Moore J, Khatri P, Aziz Y, Casteigne B, Khan M, Cheng Y, Mac Grory B, Weiss M, Ryan D, Vedovati MC, Paciaroni M, Siegler JE, Kamen S, Yu S, Leon Guerrero CR, Atallah E, De Marchis GM, Brehm A, Dittrich T, Psychogios M, Alvarado-Dyer R, Kass-Hout T, Prabhakaran S, Honda T, Liebeskind DS, Furie K (2022) Direct oral anticoagulants versus Warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke 53(3):728\u2013738","journal-title":"Stroke"},{"issue":"4","key":"2997_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1941874416648198","volume":"6","author":"AL Liberman","year":"2016","unstructured":"Liberman AL, Kamel H, Mullen MT, Mess\u00e9 SR (2016) International classification of diseases, Ninth Revision (ICD-9) diagnosis codes can identify cerebral venous thrombosis in hospitalized adults. Neurohospitalist 6(4):147\u2013150","journal-title":"Neurohospitalist"},{"issue":"1","key":"2997_CR15","first-page":"58","volume":"49","author":"JD Handley","year":"2020","unstructured":"Handley JD, Emsley HC (2020) Validation of ICD-10 codes shows intracranial venous thrombosis incidence to be higher than previously reported. Health Inf Manag 49(1):58\u201361","journal-title":"Health Inf Manag"},{"issue":"2","key":"2997_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5853\/jos.2023.00213","volume":"25","author":"S Salehi Omran","year":"2023","unstructured":"Salehi Omran S, Shu L, Chang A, Parikh NS, Zubair AS, Simpkins AN, Heldner MR, Hakim A, Kasab SA, Nguyen T, Klein P, Goldstein ED, Vedovati MC, Paciaroni M, Liebeskind DS, Yaghi S, Cutting S (2023) Timing and predictors of recanalization after anticoagulation in cerebral venous thrombosis. J Stroke 25(2):291\u2013298","journal-title":"J Stroke"},{"issue":"4","key":"2997_CR17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, Leavitt AD, Lee AYY, Macbeth F, Morgan RL, Noble S, Sexton EA, Stenehjem D, Wiercioch W, Kahale LA, Alonso-Coello P (2021) American society of hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5(4):927\u2013974","journal-title":"Blood Adv"},{"key":"2997_CR18","doi-asserted-by":"crossref","unstructured":"Bates SM, Greer IA, Hirsh J, Ginsberg JS (2004) Use of antithrombotic agents during pregnancy: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. ;126(3 Suppl):627S-644S","DOI":"10.1378\/chest.126.3_suppl.627S"},{"issue":"9","key":"2997_CR19","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/STROKEAHA.110.581223","volume":"41","author":"B Miranda","year":"2010","unstructured":"Miranda B, Ferro JM, Canh\u00e3o P, Stam J, Bousser MG, Barinagarrementeria F, Scoditti U (2010) ISCVT investigators. Venous thromboembolic events after cerebral vein thrombosis. Stroke 41(9):1901\u20131906","journal-title":"Stroke"},{"key":"2997_CR20","doi-asserted-by":"crossref","unstructured":"Dentali F, Poli D, Scoditti U, Di Minno MN, De Stefano V, Siragusa S, Kostal M, Palareti G, Sartori MT, Grandone E, Vedovati MC, Ageno W; CErebral VEin Thrombosis International Study Investigators, Falanga A, Lerede T, Bianchi M, Testa S, Witt D, McCool K, Bucherini E, Grifoni E, Coalizzo D, Benedetti R, Marietta M, Sessa M, Guaschino C, di Minno G, Tufano A, Barbar S, Malato A, Pini M, Castellini P, Barco S, Barone M, Paciaroni M, Alberti A, Agnelli G, Giorgi Pierfranceschi M, Dulicek P, Silingardi M, Federica L, Ghirarduzzi A, Tiraferri E, di Lazzaro V, Rossi E, Ciminello A, Pasca S, Barillari G, Rezoagli E, Galli M, Squizzato A, Tosetto A (2012) Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost. ;10(7):1297\u2009\u2013\u2009302","DOI":"10.1111\/j.1538-7836.2012.04774.x"},{"issue":"1","key":"2997_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12959-021-00292-9","volume":"19","author":"NI Abelhad","year":"2021","unstructured":"Abelhad NI, Qiao W, Garg N, Rojas-Hernandez CM (2021) Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer. Thromb J 19(1):37","journal-title":"Thromb J"},{"issue":"1","key":"2997_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/STROKEAHA.114.007584","volume":"46","author":"JM Coutinho","year":"2015","unstructured":"Coutinho JM, Stam J, Canh\u00e3o P, Barinagarrementeria F, Bousser MG, Ferro JM (2015) ISCVT investigators. Cerebral venous thrombosis in the absence of headache. Stroke 46(1):245\u2013247","journal-title":"Stroke"},{"key":"2997_CR23","first-page":"1836","volume":"45","author":"JM Coutinho","year":"2014","unstructured":"Coutinho JM, Gerritsma JJ, Zuurbier SM, Stam J (2014) Isolated cortical vein thrombosis. Syst Rev case Rep case Ser Stroke 45:1836\u20131838","journal-title":"Syst Rev case Rep case Ser Stroke"},{"key":"2997_CR24","doi-asserted-by":"crossref","unstructured":"Ferro JM, Canh\u00e3o P, Bousser MG, Stam J, Barinagarrementeria F (2005) ISCVT investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 36:1927\u20131932","DOI":"10.1161\/01.STR.0000177894.05495.54"},{"key":"2997_CR25","doi-asserted-by":"crossref","unstructured":"Ferro JM, Melo TP, Oliveira V, Salgado AV, Crespo M, Canh\u00e3o P et al (1995) A multivariate study of headache associated with ischemic stroke. Headache. 35:315\u2013319","DOI":"10.1111\/j.1526-4610.1995.hed3506315.x"},{"key":"2997_CR26","first-page":"494","volume":"47","author":"TP Melo","year":"1996","unstructured":"Melo TP, Pinto AN, Ferro JM (1996) Headache intracerebral. Hematomas Neurol 47:494\u2013500","journal-title":"Headache Intracerebral Hematomas Neurol"},{"issue":"8","key":"2997_CR27","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.020","volume":"26","author":"T Duman","year":"2017","unstructured":"Duman T, Uluduz D, Midi I, Bektas H, Kablan Y, Goksel BK, Milanlioglu A, Necioglu Orken D, Aluclu U, VENOST Study Group (2017) A Multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis 26(8):1848\u20131857","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"17","key":"2997_CR28","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","volume":"382","author":"G Agnelli","year":"2020","unstructured":"Agnelli G, Becattini C, Meyer G, Mu\u00f1oz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M (2020) Caravaggio Investigators. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med 382(17):1599\u20131607","journal-title":"N Engl J Med"},{"issue":"12","key":"2997_CR29","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1001\/jamaneurol.2019.2764","volume":"76","author":"JM Ferro","year":"2019","unstructured":"Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canh\u00e3o P, Karpov D, Nagel S, Posthuma L, Roriz JM, Caria J, Fr\u00e4ssdorf M, Huisman H, Reilly P, Diener HC, RE-SPECT CVT Study Group (2019) Safety and Efficacy of Dabigatran Etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol 76(12):1457\u20131465","journal-title":"JAMA Neurol"},{"issue":"4","key":"2997_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0333102421999045","volume":"41","author":"JF Rothrock","year":"2021","unstructured":"Rothrock JF, Diener HC (2021) Headache secondary to cerebrovascular disease. Cephalalgia 41(4):479\u2013492","journal-title":"Cephalalgia"},{"issue":"4","key":"2997_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"AP Carnicelli","year":"2022","unstructured":"Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Cecilia Bahit M, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, Fox AA, Gencer K, Halperin B, Hijazi JL, Hohnloser Z, Hua SH, Hylek K, Toda Kato E, Kuder E, Lopes J, Mahaffey RD, Oldgren KW, Piccini J, Ruff JP, Steffel CT, Wojdyla J, Granger D (2022) COMBINE AF (a collaboration between multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) investigators. Direct oral anticoagulants Versus Warfarin in patients with Atrial Fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation 145(4):242\u2013255","journal-title":"Circulation"},{"issue":"12","key":"2997_CR32","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","volume":"124","author":"N van Es","year":"2014","unstructured":"van Es N, Coppens M, Schulman S, Middeldorp S, B\u00fcller HR (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 124(12):1968\u20131975","journal-title":"Blood"},{"issue":"4","key":"2997_CR33","first-page":"733","volume":"116","author":"YW Cheung","year":"2016","unstructured":"Cheung YW, Middeldorp S, Prins MH, Pap AF, Lensing AW, Ten Cate-Hoek AJ, Villalta S, Milan M, Beyer-Westendorf J, Verhamme P, Bauersachs RM, Prandoni P, Einstein PTS, Investigators Group (2016) Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin\/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis. Thromb Haemost 116(4):733\u2013738","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02997-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-024-02997-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02997-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T08:08:39Z","timestamp":1723190919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-024-02997-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,2]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["2997"],"URL":"https:\/\/doi.org\/10.1007\/s11239-024-02997-w","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,2]]},"assertion":[{"value":"30 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}